DobbieJ.W.From philosopher to fish: The comparative anatomy of the peritoneal cavity as an excretory organ and its significance for peritoneal dialysis in man.Perit Dial Int.1988; 8: 3–6.
2.
MactierR.A., KhannaR., TwardowskiZ.J., NolphK.D.Role of peritoneal cavity lymphatic absorption in peritoneal dialysis.Kidney Int.1987; 32: 165–172.
3.
SmebyL.C., WideröeT-E, JörstadS.Individual differences in water transport during continous peritoneal dialysis.ASAIO J.1981; 4: 17–27.
4.
RippeB., StelinG., AhlmenJ.Lymph flow from the peritoneal cavity in CAPD patients. In: MakerJ.F., WinchesterJ.F., eds. Frontiers in peritoneal dialysis.New York: Field, Rich, and Associates; 1986: 24–30.
De PaepeM., BepaireF., SchelstraeteK., LameireN.Comparison of different volume markers in peritoneal dialysis.J Lab Clin Med.1988; 111: 421–429.
7.
CanaudB., Liendo-LiendoC., ClaretG., MionH., MionC.Etude in situ de la cinétique de I'ultrafiltration en cours de dialyse péritonéale avec périodes de diffusion prolongeé.Nephrologie.1980; 1: 126–132.
8.
KredietR.T., BoeschotenE.W., ZuyderhoudtF.M.J., StrackeeJ., AriszL.Simple assessment of the efficacy of peritoneal transport in continuous ambulatory peritoneal dialysis patients.Blood Purif.1986; 4: 194–203.
9.
Guy tonA.C.Textbook of medical physiology, 7th ed.Philadelphia: Saunders; 1981: 348–360.
10.
RoseB.D.Clinical physiology of acid-base and electrolyte disorders, 2nd ed.New York: McGraw-Hill; 1984: 3–42.
11.
TwardowskiZ.J., KhannaR., NolphK.D.Osmotic agents and ultrafiltration in peritoneal dialysis.Nephron.1986; 42: 93–101.
12.
TwardowskiZ.J., KhannaR., NolphK.D.Intra-abdominal pressures during natural activities in patients treated with continuous ambulatory peritoneal dialysis.Nephron.1986; 44: 129–135.
13.
HenderdonL.Ultrafiltration with peritoneal dialysis. In: NolphK.D., ed. Peritoneal Dialysis, 2nd ed.Boston: Martinus Nijhoff; 1985: 159–177.
14.
RippeB., PerryM.A., GrangerD.N.Permselectivity of the peritoneal membrane.Microvasc Res.1985; 29: 89–102.
15.
KredietR.T., BoeschotenE.W., ZuyderhoudtF.M.J., AriszL.The relationship between peritoneal glucose absorption and body fluid loss by ultrafiltration during continuous ambulatory peritoneal dialysis.Clin Nephrol.1987; 27: 51–55.
16.
MistryC.D., MallickN.P., GokalR.Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchanges.Lancet.1987; 2: 178–182.
17.
HigginsJ.T., GrossM.L., SomaniP.Patient tolerance and dialysis effectiveness of a glucose polymer-containing peritoneal dialysis solution.Perit Dial Bull.1984; 4: S131–S133.
18.
RubinJ., JonasQ., PlanchA., BowerJ., KleinE.Substitution of a starch polymer for glucose in peritoneal dialysis.Nephron.1985; 39: 40–46.
KredietR.T., StruijkD.G., BoeschotenE.W., HoekF.J., AriszL.Measurement of intraperitoneal fluid kinetics in CAPD patients by means of autologous haemoglobin.Neth J Med.1988; 33: 281–290.
21.
NolphK.D., TwardowskiZ.J., PopovichR.P., RubinJ.Equilibration of peritoneal dialysis solutions during long-dwell exchanges.J Lab Clin Med.1979; 93: 246–256.
22.
NolphK.D., HanoJ.E., TeschanP.E.Peritoneal sodium transport during hypertonic peritoneal dialysis.Ann Intern Med.1969; 70: 931–941.
23.
NolphK.D., MillerF.N., PyleK.W., PopovichR.P., SorkinM.I.An hypothesis to explain the ultrafiltration characteristics of peritoneal dialysis.Kidney Int.1981; 20: 543–548.
24.
RandersonD.H., FarrelP.C.Mass transfer properties of the human peritoneum.ABAIO J.1980; 3: 140–146. 25. Segel IH. Enzyme kinetics. New York: John Wiley; 1975: 18–99. 26. Holford, NHG, Sheiner LB. Kinetics of pharmacologic response. Pharmac Ther. 1982; 16: 143–163.
25.
ShearL., SwartzC., ShinabergerJ.A., BarryK.G.Kinetics of peritoneal fluid absorption in adult man.N Engl J Med.1965; 272: 123–127.
26.
DaugirdasJ.T., IngT.S., GandhiV.C., HanoJ.E., ChenW.T., YuanL.Kinetics of peritoneal fluid absorption in patients with chronic renal failure.J Lab Clin Med.1980; 95: 351–361.
27.
NolphK.D., MactierR., KhannaR., TwardowskiZ.J., MooreH., McGaryT.The kinetics of ultrafiltration during peritoneal dialysis: The role of lymphatics.Kidney Int.1987; 32: 219–226.
28.
CheekT.R., TwardowskiZ.J., MooreJ.L., NolphK.D.High molecular weight gelatin isocyanate absorption from the peritoneal cavity of rats. (Abstract) Perit Dial Bull.1987; 7: S16.
AllenL.On the penetrability of the lymphatics of the diaphragm.Anat Rec.1956; 124: 639–657.
31.
MactierR.A., KhannaR., TwardowskiZ.J., MooreH., NolphK.D.Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis.J Clin Invest.1987; 80: 1311–1316.
32.
KredietR.T., BoeschotenE.W., AriszL.Letter to the editor.Clin Nephrol.1987; 4: 209.
33.
SpencerP.C., FarrellP.C.Solute and water transfer kinetics in CAPD. In: GokalR., ed. Continuous ambulatory peritoneal dialysis.Edinburgh: Churchill Livingstone;1986: 38–55.
34.
FlessnerM.F., DedrickR.L., FenstermacherJ.D., BlasbergR.G., SleberS.M.Peritoneal absorption of macromolecules. In: MakerJ.F., WinschesterJ.F., eds. Frontiers in peritoneal dialysis.New York: Field, Rich, and Associates; 1986: 41–46.
35.
StruijkD.G., KredietR.T., KoomenG.C.M., BoeschotenE.W., Vd ReijdenH.J., AriszL.Measurement of lymphatic absorption in CAPD patients by intravenous and intraperitoneal administration of inulin. (Abstract) Kidney Int.1988; 34: 561.
36.
EsperancaM.J., CollinsD.L.Peritoneal dialysis efficiency in relation to body weight.J Paediat Burg.1966; 1: 162–169.
37.
AlonU., Bar-MaorJ.A., Bar-JosephG.Effective peritoneal dialysis in an infant with extensive resection of the small intestine.Am J Nephrol.1988; 8: 65–67.
38.
BalfeJ.W., VigneuxA., WillumsenJ., HardyB.E.The use of CAPD in children with end-stage renal disease.Perit Dial Bull.1981; 1: 35–38.
MactierR.A., KhannaR., MooreH., RussJ., NolphK.D., GroshongT.Kinetics of peritoneal dialysis in children: Role of lymphatics.Kidney Int.1988; 34: 82–88.
41.
RubinJ., Mc FarlandS., HellemsE.W., BowerJ.D.Peritoneal dialysis during peritonitis.Kidney Int.1981; 19: 460–464.
42.
RajaR.M., KramerM.S., BarberK.Solute transport and ultrafiltration during peritonitis in CAPD patients.ABAIO J.1984; 7: 8–11.
43.
KredietR.T., ZuyderhoudtF.M.J., BoeschotenE.W., AriszL.Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients.Eur J Clin Invest.1987; 17: 43–52.
44.
KredietR.T., StruijkG.D., BoeschotenE.W., AriszL.The effect of peritonitis on lymphatic fluid absorption from the peritoneal cavity. (Abstract) Nephrol Dial Transplant.1988; 3: 556.
KredietR.T., BoeschotenE.W., StruijkD.G., AriszL.Differences in the peritoneal transport of water, solutes and proteins between dialysis with two and with three litre exchanges.Nephrol Dial Transplant.1988; 2: 198–204.
47.
FallerB., MarichalJ.F.Loss of ultrafiltration in continuous ambulatory peritoneal dialysis: Clinical data. In: GahlG.M., KesselM., NolphK.D., eds. Advances in peritoneal dialysis.Amsterdam: Excerpta Medica; 1981: 227–232.
48.
OreopoulosD.G., GotloibL., CalderanroV., KhannaR.For how long can peritoneal dialysis be continued?Can Med Ass J.1981; 124: 12–13.
49.
MionC.A review of seven years home peritoneal dialysis. In: RobinsonB.H.B., HawkinsJ.B., DavisonA.M., eds. Proceedings of the European Dialysis and Transplant Association 18.London: Pitman;1981: 91–108.
50.
SlingemeyerA., CanaudB., MionC.Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis. An epidemiological study.Nephron.1983; 33: 133–138.
51.
ManuelM.A., University of Toronto Collaborative Dialysis Group. Failure of ultrafiltration in patients on CAPD.Perit Dial Bull.1983; 3: S38–S40.
52.
WideröeT-E, SmebyL.C., MjlilandS., DahlK., BergK.J., AasT.W.Long-term changes in transperitoneal water transport during continuous ambulatory peritoneal dialysis.Nephron.1984; 38: 238–247.
53.
KredietR.T., BoeschotenE.W., ZuyderhoudtF.M.J., AriszL.Peritoneal transport characteristics of water, lowmolecular weight solutes and proteins during longterm continuous ambulatory peritoneal dialysis.Perit Dial Bull.1986; 6: 61–65.
54.
StruijkD.G., KredietR.T., KoomenG.C.M., BoeschotenE.W., Vd ReijdenH.J., AriszL.Functional characteris tics of the peritoneal membrane in long duration CAPD. (Abstract) Kidney Int.1988; 34: 561.
55.
MactierR.A., KhannaR., TwardowskiZ.J., NolphK.D.Ultrafiltration failure in continuous ambulatory peritoneal dialysis due to excessive peritoneal cavity lymphatic absorption.Am J Kidney Dis.1987; 6: 461–466.
56.
SlingeneyerA., MionC., MouradG., CanaudB., FallerB., BeraudJ.J.Progressive sclerosing peritonitis: A late and severe complication of maintenance peritoneal dialysis.Trans Am Soc Artif Intern Organs.1983; 29: 633–640.
57.
RottembourgJ., GahlG.M., PoignetJ.L.Severe abdominal complications in patients undergoing continuous ambulatory peritoneal dialysis in: DavisonA.M., GuillouP.J., eds. Proceedings of the European Dialysis and Transplant Association 20.London: Pitman; 1983: 236–242.
58.
ManonJ., PostlethwaiteR.J., MallickH.P., GokalR.Sclerosing encapsulating peritonitis and other complications of CAPD peritonitis. In: MaherJ.F., WinchesterJ.F., eds. Frontiers in peritoneal dialysis.New York: Field, Rich, and Associates; 1986: 634–637.
59.
McWhinnieD.L., BradleyJ.A., BramwellS.P.Sclerosing peritonitis-A further complication of CAPD. In: MaherJ.F., WinchesterJ.F., eds. Frontiers in peritoneal dialysis.New York: Field, Rich, and Associates; 1986: 638–642.
60.
RottembourgJ., IssadB., LangloisP., De GrocF., LegrainM.Sclerosing encapsulating peritonitis during CAPD. Evaluation of the potential risk factors. In: MaherJ.F., WinchesterJ.F., eds. Frontiers in peritoneal dialysis.New York: Field, Rich, and Associates; 1986: 643–649.
61.
VergerC., CellcoutP.Peritoneal permeability and en capsulating peritonitis.Lancet.1985; 1: 986–987.
62.
KredietR.T., StruijkD.G., BoeschotenE.W.The time course of peritoneal transport kinetics in continuous ambulatory peritoneal dialysis patients who develop sclerosing peritonitis. Submitted for publication.
MaherJ.F., HirszelP., BennetR.R., ChakrabartiE.Augmentation of peritoneal hydraulic permeability by am -photericin B: Locus of action.Perit Dial Bull.1984; 4: 299–301.
65.
StruijkD.G., KredietR.T., BoeschotenE.W., RietraPJGM, AriszL.Antifungal treatment of candida peritonitis in continuous ambulatory peritoneal dialysis patients.Am J Kidney Dis.1987; 9: 66–70.
66.
FijenJ.W., StruijkD.G., KredietR.T., BoeschotenE.W., De VriesJ.P., AriszL.Dialysate leucocytosis in CAPD patients without clinical infection.Neth J Med.1988; 33: 270–280.
67.
GrahameG.R., TorchiaM.G., DankewichK.A., FergusonI.A.Surface-active material in peritoneal effluent of CAPD patients.Perit Dial Bull.1985; 5: 109–111.
68.
Di PaoloN., BuoncristianiU., CapotondoL., GaggiottiE., De MiaM., RossiP., SansoniE., BeriniM.Phosphatidylcholine and peritoneal transport during peritoneal dialysis.Nephron.1986; 44: 365–370.
MactierR.A., KhannaR., MooreH., TwardowskiZ.J., NolphK.Phosphatidylcholine enhances the efficiency of peritoneal dialysis by reducing lymphatic reabsorption. (Abstract) Kidney Int.1988; 33: 247.
71.
MactierR.A., KhannaR., MooreH., TwardowskiZ.J., NolphK.D.Pharmacological reduction of lymphatic absorption from the peritoneal cavity increases net ultrafiltration and solute clearances in peritoneal dialysis.Nephron.1988; 50: 229–232.
72.
StruijkD.G., Vd ReijdenH.J., KredietR.T., KoomenG.C.M., AriszL.The effect of phosphatidylcholine on peritoneal transport and lymphatic absorption in a CAPD patient with sclerosing peritonitis.Nephron, in press.
73.
LamperiS., CarozziS., NasiniM.G.Calcium antagonists improve ultrafiltration in patients on continuous ambulatory peritoneal dialysis (CAPD).Trans Am Soc Artif Intern Organs.1987; 33: 657–663.
74.
HendersonL.W., NolphK.D.Altered permeability of the peritoneal membrane after using hypertonic peritoneal dialysis fluid.J Clin Invest.1969; 48: 992–1001.
75.
HendersonL.W.The problem of peritoneal membrane area and permeability.Kidney Int.1973; 3: 409–410.
HendersonL.W.Biophysics of ultrafiltration and hemofiltration. In: DrukkerW., ParsonsF.M., MaherJ.F., eds. Replacement of renal function by dialysis, 2nd ed.Boston: Martinus Nijhoff, 1983: 242–264.
78.
KredietR.T., ZuyderhoudtF.M.J., BoeschotenE.W., AriszL.Peritoneal permeability to proteins in diabetic and non-diabetic continuous ambulatory peritoneal dialysis patients.Nephron.1986; 42: 133–140.
79.
SteinhauerH.B., SchollmeyerP.Prostaglandin-mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysis.Kidney Int.1986; 29: 584–590.
BlumenkrantzM.J., GahlG.M., KoppleJ.D.Protein losses during peritoneal dialysis.Kidney Int.1981; 19: 593–602.
82.
TwardowskiZ.J., NolphK.D., ProwantB.F., MooreH.L.Efficiency of high volume, low frequency continuous ambulatory peritoneal dialysis (CAPD).Trans Am Soc Artif Intern Organs.1984; 29: 53–57.
83.
BrennerB.M., HostetterT.H., HulmesH.D.Molecular basis of proteinuria of glomerular origin.N Engl J Med.1978; 298: 826–833.
84.
CarrieB.J., MeyersB.D.Proteinuria and functional characteristics of the glomerular barries in diabetic nephropathy.Kidney Int.1980; 17: 669–676.
85.
CarrieB.J., SalyerW.R., MyersB.D.Minimal change nephropathy: An electrochemical disorder of the glomerular membrane.Am J Med.1981; 262–268.
86.
HirszelP., ChakrabartiE.K., BennettR.R., MaherJ.F.Permselectivity of the peritoneum to neutral dextrans.Trans Am Soc Artif Intern Organs.1984; 30: 625–628.
87.
HirszelP., MaherJ.F., ChakrabartiE., BennettR.R.Maximal peritoneal pore size determined by dextran. In: MaherJ.F., WinchesterJ.F., eds. Frontiers in peritoneal dialysis.New York: Field, Rich, and Associates; 1986: 37–40.
HirszelP., Shea-DonohueT., ChakrabartiE., MontcalmE., MaherJ.F.The role of the capillary wall in restricting diffusion of macromolecules.Nephron.1988; 49: 58–61.
90.
GotloibL., Bar SellaP., JaichenkoJ., ShustachA.Ruthenium-red-stained polyanionic fixed charges in peritoneal microressels.Nephron.1987; 47: 22–28.
91.
KredietR.T., KoomenG.C.M., KoopmanM.G.The peritoneal transport of serum proteins and neutral dextran in CAPD patients.Kidney Int, in press.
92.
AmairP., KhannaR., LeibelB.Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease.N Engl J Med.1982; 306: 625–630.
93.
CantaluppiA.CAPD and systemic diseases.Clin Nephrol.1988; 30, suppl 1: S8–S12.
94.
NolphK.D., StoltzM.L., MaherJ.F.Altered peritoneal permeability in patients with systemic vasculitis.Ann Intern Med.1971; 75: 753–755.
95.
BrownS.T., AhearnD.J., NolphK.D.Reduced peritoneal clearances in scleroderma increased by intraperitoneal isoproterenol.Ann Intern Med.1973; 78: 891–894.
96.
RubinJ., WalshD., BowerJ.D.Diabetes, dialysate losses and serum lipids during continuous ambulatory peritoneal dialysis.Am J Kidney Dis.1987; 10: 104–108.
97.
RubinJ., ReedV., AdairC.Effect of intraperitoneal insulin on solute kinetics in CAPD.Am J Med Sci.1986; 291: 81–87.
98.
KredietR.T.Peritoneal permeability in continuous ambulatory peritoneal dialysis. Thesis. University of Amsterdam1986: 59–69.
99.
SelgasR., MaderoR., MuftozJ.Functional peculiarities of the peritoneum in diabetes mellitus.Dial Transplant.1988; 17: 419–421.
KredietR.T., BoeschotenE.W., ZuyderhoudtF.M., AriszL.Permeability of the peritoneum to proteins in CAPD patients with systemic disease. In: DavisonA.M., GuillouP.J., eds. Proceedings of the European Dialysis and Transplant Association European Renal Association 22.London: Bailliere Tindall; 1985: 405–409.